Ebola’s legacy reveals an uncomfortable truth: environmental sustainability is not just conservation, it is disease ...

At least nine cases of the rare viral hemorrhagic fever have been confirmed, the World Health Organization said Friday.

Opaganib and RHB-107 show a distinct synergy in viral inhibition while maintaining cell viability in preclinical studies. Opaganib is believed to be the first host-directed molecule to show activity ...

More than half of survivors of the Sudan Ebola virus still suffer serious health problems two years post-infection and the virus can persist in semen and breast milk for months after recovery, ...

Abhilash I. Chiramel, Logan Banadyga, Jonathan D. Dougherty, Darryl Falzarano, Cynthia Martellaro, Dominique Brees, R. Travis Taylor, Hideki Ebihara, Sonja M. Best ...

Ebola and its epidemiological, political and cultural consequences took the stage during a multi-disciplinary panel of four Brown faculty members in Salomon 101 Thursday evening. The discussion took ...

In 2010, Ahmet Ali Yanik published his first paper on the rapid detection of Ebola virus using new biosensor technology he and colleagues at Boston University had invented. But he found there was ...

The US Food and Drug Administration (FDA) has approved the first vaccine for the prevention of Ebola caused by the deadly Zaire strain of the virus, which killed more than 11,000 people during the ...

As tourism businesses raise alarm, economists remain cautiously optimistic that if the Ebola outbreak doesn’t last long, it will not have dire effects on Uganda’s economy, which like many across the ...

A Lassa fever vaccine candidate was safe and produced a strong immune response in adults in the United States and Liberia, ...